[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Merck & Company (MRK)

Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Stocks Rise Before the Open as Investors Weigh Big Tech Earnings, Iran War News

June S&P 500 E-Mini futures (ESM26) are up +0.15%, and June Nasdaq 100 E-Mini futures (NQM26) are up +0.22% this morning as investors digest earnings reports from big U.S. tech companies and the latest developments in the Iran war.

Alphabet (GOOGL) climbed over +6% in pre-market trading after Google’s parent company reported stronger-than-expected Q1 results. Also, Amazon.com (AMZN) gained more than +2% in pre-market trading after the e-commerce and technology giant posted strong Q1 results, issued above-consensus Q2 revenue guidance, and CEO Andy Jassy said the company now holds over $225 billion in revenue commitments for Trainium, AWS’s AI chip. At the...

Fundamentals

See More
  • Market Capitalization, $K 274,033,056
  • Shares Outstanding, K 2,469,879
  • Annual Sales, $ 65,011 M
  • Annual Income, $ 18,254 M
  • EBIT $ 22,107 M
  • EBITDA $ 27,945 M
  • 60-Month Beta 0.26
  • Price/Sales 4.18
  • Price/Cash Flow 9.63
  • Price/Book 5.19

Options Overview Details

View History
  • Implied Volatility 31.33% (-3.92%)
  • Historical Volatility 25.42%
  • IV Percentile 63%
  • IV Rank 51.90%
  • IV High 40.30% on 05/15/25
  • IV Low 21.66% on 12/08/25
  • Expected Move (DTE 7) 4.28 (3.92%)
  • Put/Call Vol Ratio 0.70
  • Today's Volume 50,492
  • Volume Avg (30-Day) 22,462
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 494,293
  • Open Int (30-Day) 493,896
  • Expected Range 104.90 to 113.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.73
  • Number of Estimates 6
  • High Estimate $2.18
  • Low Estimate $-0.20
  • Prior Year $2.13
  • Growth Rate Est. (year over year) -18.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
107.90 +1.19%
on 04/29/26
124.00 -11.95%
on 04/09/26
-8.92 (-7.55%)
since 03/30/26
3-Month
107.90 +1.19%
on 04/29/26
125.14 -12.75%
on 02/25/26
-1.09 (-0.99%)
since 01/30/26
52-Week
73.31 +48.93%
on 05/15/25
125.14 -12.75%
on 02/25/26
+23.98 (+28.15%)
since 04/30/25

Most Recent Stories

More News
Merck (NYSE:MRK) Surprises With Q1 CY2026 Sales

Merck (NYSE:MRK) Surprises With Q1 CY2026 Sales

MRK : 109.18 (-1.60%)
Merck: Q1 Earnings Snapshot

Merck: Q1 Earnings Snapshot

MRK : 109.18 (-1.60%)
Stocks Rise Before the Open as Investors Weigh Big Tech Earnings, Iran War News

June S&P 500 E-Mini futures (ESM26) are up +0.15%, and June Nasdaq 100 E-Mini futures (NQM26) are up +0.22% this morning as investors digest earnings reports from big U.S. tech companies and the latest...

TER : 343.47 (+12.12%)
GOOGL : 384.80 (+9.96%)
META : 611.91 (-8.55%)
AAPL : 271.35 (+0.44%)
SNDK : 1,096.51 (+3.04%)
BNP.FP : 89.230 (-1.41%)
NXPI : 293.59 (+1.50%)
MRK : 109.18 (-1.60%)
GLE.FP : 68.440 (-3.59%)
ESM26 : 7,250.25 (+0.09%)
MSFT : 407.78 (-3.93%)
UMG.A.DX : 17.828 (-7.29%)
Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones

Sales Growth Driven by Continued Strength in Oncology and Animal Health, Plus Increasing Contributions From Launches Total Worldwide Sales Were $16.3 Billion...

MRK : 109.18 (-1.60%)
Merck's Keytruda Dependency Gets Its Most Important Quarterly Stress Test Yet

Barchart Research What to Expect from MRK Earnings MRK Generated April 29, 2026 Current Price $110.95 EPS Estimate $$-1.51 Consensus Rating Moderate Buy Average Move 3.73% Merck's Keytruda Dependency Gets...

MRK : 109.18 (-1.60%)
Merck (MRK) Q1 Earnings Report Preview: What To Look For

Merck (MRK) Q1 Earnings Report Preview: What To Look For

MRK : 109.18 (-1.60%)
Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke

The Yankees, Red Sox, Phillies, Braves, Astros, Cardinals, Giants, Padres, and Angels are joining Merck to help educate fans about high bad cholesterol and how it may increase the risk of heart attack...

MRK : 109.18 (-1.60%)
3 Biotech Stocks That Could Benefit from the Patent Cliff

Biotech M&A is surging ahead of a $300B patent cliff. Here are 3 gene-editing stocks investors are watching as potential acquisition targets

BEAM : 30.33 (+3.23%)
CRSP : 52.34 (+3.21%)
MRK : 109.18 (-1.60%)
BMY : 60.59 (+5.21%)
NTLA : 13.48 (+8.32%)
Stocks Set for Muted Open as Investors Await Big Tech Earnings and Fed Meeting; Middle East Developments in Focus

June S&P 500 E-Mini futures (ESM26) are down -0.09%, and June Nasdaq 100 E-Mini futures (NQM26) are up +0.06% this morning as investors refrain from making big bets at the start of a busy week featuring...

GOOGL : 384.80 (+9.96%)
AAPL : 271.35 (+0.44%)
SNDK : 1,096.51 (+3.04%)
CVX : 193.31 (+0.57%)
MRK : 109.18 (-1.60%)
ESM26 : 7,250.25 (+0.09%)
MSFT : 407.78 (-3.93%)
MA : 502.92 (-4.25%)
QCOM : 179.58 (+15.12%)
STX : 673.64 (+4.72%)
V : 329.84 (-1.50%)
WDC : 434.52 (+5.27%)
Mega-Cap Earnings, FOMC and Other Key Things to Watch this Week

Markets enter a pivotal week with key Mega-Cap earnings and Fed policy the main tings to watch along with any news from Iran.

META : 611.91 (-8.55%)
GOOGL : 384.80 (+9.96%)
AAPL : 271.35 (+0.44%)
CVX : 193.31 (+0.57%)
KO : 78.76 (-0.14%)
F : 12.08 (-1.31%)
GM : 76.89 (+0.35%)
MRK : 109.18 (-1.60%)
AMGN : 346.25 (+2.43%)
BMY : 60.59 (+5.21%)
MSFT : 407.78 (-3.93%)
SBUX : 105.33 (-0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda,...

See More

Key Turning Points

3rd Resistance Point 115.01
2nd Resistance Point 113.63
1st Resistance Point 111.40
Last Price 109.18
1st Support Level 107.79
2nd Support Level 106.41
3rd Support Level 104.18

See More

52-Week High 125.14
Last Price 109.18
Fibonacci 61.8% 105.34
Fibonacci 50% 99.22
Fibonacci 38.2% 93.11
52-Week Low 73.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.